Filter announcements
Loading...
Balaxi Pharmaceuticals Ltd is an IPR-based pharmaceutical Company engaged in producing, stocking, selling, and supplying branded and generic medicines.
Balaxi Pharmaceuticals reported zero activity regarding physical share transfer re-lodgements for the period. Zero requests were received, processed, approved, or rejected, indicating a settled holding structure with no operational impact on equity or liquidity for retail investors.
Balaxi Pharma's Hyderabad facility secured WHO-GMP Certification, a key milestone boosting manufacturing and quality. Production of initial products has started, enhancing its portfolio for global markets.
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Change in Director(s) of the company.
BALAXI PHARMACEUTICALS LIMITED has submitted the Exchange a copy Srutinizers Report of Annual General Meeting held on 24th August, 2026. Further, the company has informed the Exchange regarding Voting Results.
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Proceedings of the 83rd Annual General Meeting held on 24th August, 2026